Oramed Pharmaceuticals Inc (ORMP) — Cash Flow Reinvestment Rate
Oramed Pharmaceuticals Inc (ORMP) has a Cash Flow Reinvestment Rate of 45.70x as of June 2024, reinvesting $94.66 Million (capex $17.06 plus investments $94.66 Million) from operating cash flow of $2.07 Million. Explore reinvestment intensity of Oramed Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oramed Pharmaceuticals Inc Cash Flow Reinvestment Rate (2016–2016)
Historical reinvestment intensity for Oramed Pharmaceuticals Inc across 1 annual periods. Also explore ORMP total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Oramed Pharmaceuticals Inc (2016–2016)
Year-by-year capital reinvestment analysis for Oramed Pharmaceuticals Inc. For live market cap and broader valuation context, see market cap of Oramed Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.00x | $9.00K | $4.66 Million | $9.00K | — |